NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers

Helena A. Yu, Maria E. Arcila, Natasha Rekhtman et al. · Clinical Cancer Research · 2013 · 2.4K citations · Full text

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

Matthew D. Burstein, Anna Tsimelzon, Graham M. Poage et al. · Clinical Cancer Research · 2014 · 1.3K citations · Full text

Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways

Mirjam C. Boelens, Tony J. Wu, Barzin Y. Nabet et al. · Cell · 2014 · 782 citations · Full text

Breast Oncology, Exosomes, Medicine +12

High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival

Michael Reedijk, Silvia Odorcic, Lynn Chang et al. · Cancer Research · 2005 · 778 citations · Full text

Tumor Biology, Breast Oncology, Oncology +14

Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding et al. · Journal of Clinical Oncology · 2008 · 665 citations · Full text